Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab

Obesity Research

Volumn 12, Issue 4, 2004, Pages 734-739

  Di Rocco, Paola ^a   Manco, Melania ^a   Rosa, Giuseppina ^a   Greco, Aldo V ^a   Mingrone, Geltrude ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Euglycemic hyperinsulinemic clamp; Infliximab; Insulin sensitivity; Tumor necrosis factor receptors

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 4; INFLIXIMAB; INSULIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY; MUSCLE PROTEIN; SLC2A4 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ARTICLE; BIOPSY; BLOOD; BODY COMPOSITION; CHEMISTRY; DIET RESTRICTION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; IMMUNITY; INSULIN RESISTANCE; MALE; METABOLISM; OBESITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BIOPSY; BLOOD GLUCOSE; BODY COMPOSITION; FASTING; FEMALE; GENE EXPRESSION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; IMMUNITY; INSULIN; INSULIN RESISTANCE; MALE; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042725473     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2004.86     Document Type: Article

References (25)

1. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med. 1999;245:621-5.
2. Peraldi P Spiegelman BM. Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-alpha. J Endocrinol. 1997;155:219-20.
3. Miyazaki Y, Pipek R, Mandarino LJ, De Fronzo RA. Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. 2003;J27:88-94.
4. Fliers JS. Diabetes: the missing link with obesity? Nature. 2001;18:292-3.
5. Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance Exp Clin Endocrinol. 1999;107:119-25.
6. Hube F, Hauner H. The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res. 1999;31:626-31.
7. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996;15:97:1111-6.
8. Knight DM, Trinh H, Le J, et al. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Molec Immunol. 1993;30:1443-53.
9. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94:1543-9.
10. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
11. Ofei F, Hurel S, Newkirk J, Sopwith M, Taylor R. Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in petients with NIDDM. Diabetes. 1996;45:881-5.
12. Paquot N, Castillo MJ, Lefebvre PJ, Scheen AJ. No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor:Fc fusion protein in obese insulin resistant patients. J Clin Endocrinol Metab. 2000;85:1316-9.
13. Moore FD, Olesen KH, McMurrey JD, Parker HV, Ball MR, Boyden CM, eds. The Body Cell Mass and its Supporting Environment. Philadelphia, PA: Saunders; 1963.
14. Culebras JM, Moore FD. Total body water and the exchangeable hydrogen I. Theoretical calculations of nonaqueous exchangeable hydrogen in men. Am J Physiol. 1977;232:R54-9.
15. Heymsfield SB, Lichtman S, Baumgartner RN, et al. Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr. 1990;52:52-8.
16. DeFronzo RA, Tobin JD, Anders R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237 214-23.
17. Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine. 1995;7: 251-9.
18. Cope AP, Londei M, Chu NR, et al. Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest. 1994;94:749-60.
19. Hauner H, Bender M, Haastert B, Hube F. Plasma concentration of soluble TNF-alpha receptors in obese subjects Int J Obes Relat Metab Disord. 1998;22:1239-43.
20. Dzienis-Straczkowska S, Straczkowski M, Szelachowska M, Stepien A, Kowalska I, Kinalska I. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care. 2003;26:875-80.
21. Straczkowski M, Kowalska I, Dzienis-Straczkowska S, et al. Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol. 2001;14:273-80.
22. Fernandez-Real JM, Broch M, Ricart W, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes. 1998;47:1757-62.
23. Bastard JP, Jardel C, Bruckert E, Vidal H, Hainque B. Variations in plasma soluble tumor necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab. 2000;2:323-5.
24. Bullo M, Garcia-Lorda P, Salas-Salvado J. Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal weight and obese women: effect of adiposity and diabetes, Eur J Endocrinol. 2000;146: 325-31.
25. Mingrone G, Rosa G, Di Rocco P, et al. Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord. 2002;26:1165-72.